V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215049 | 20155453 | null | 77 | Palliative (P) | null | 2018-12-16 | Sorafenib | 02 | N | SORAFENIB | 101655671 |
| 20215050 | 20155454 | 1.72 | 86.5 | Palliative (P) | null | 2020-11-02 | Capecitabine 35days + RT | 02 | N | CAPECITABINE + RT | 100159587 |
| 20215052 | 20155455 | 1.76 | 61 | null | null | 2016-01-06 | Trial Unspecified | N | null | EOX | 101748537 |
| 20215053 | 20155456 | 1.66 | 81.4 | Curative (C) | 2020-04-13 | 2020-04-13 | EOX | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100815574 |
| 20215058 | 20155457 | 1.67 | null | null | null | 2017-03-06 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 100328862 |
| 20215061 | 20155458 | 1.72 | 71.1 | null | null | 2020-07-27 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100336048 |
| 20215062 | 20155459 | 1.75 | 78.05 | null | 2020-01-07 | 2020-01-09 | Sorafenib | 02 | null | SORAFENIB | 101550124 |
| 20215063 | 20155460 | 1.7 | 63.5 | Palliative (P) | null | 2021-12-22 | Trial Unspecified | 01 | N | TRIAL | 100228842 |
| 20215066 | 20155461 | 1.88 | 130.7 | Palliative (P) | 2017-12-11 | 2017-12-14 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100416258 |
| 20215067 | 20155462 | 1.57 | 57.4 | null | 2019-08-05 | 2019-08-21 | EOX | N | null | EOX | 101088812 |
| 20215068 | 20155463 | 1.6 | 96.2 | Palliative (P) | 2019-08-22 | 2019-10-17 | EOX | 2 | N | EOX | 100778076 |
| 20215071 | 20155464 | 1.74 | 63.2 | null | 2018-01-16 | 2018-08-12 | EOX | Y | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101475060 |
| 20215076 | 20155465 | 1.51 | 63.5 | Palliative (P) | 2021-12-18 | 2021-12-31 | EOX | N | null | EOX | 100048467 |
| 20215077 | 20155466 | 1.59 | 73.8 | Adjuvant (A) | 2018-09-28 | 2018-10-23 | Capecitabine 35days + RT | N | N | CAPECITABINE + RT | 100987567 |
| 20215078 | 20155467 | 0 | 61.9 | null | 2018-09-16 | 2018-09-24 | EOX | 1 | null | SORAFENIB | 100591288 |
| 20215082 | 20155468 | 1.66 | null | Palliative (P) | 2019-07-11 | 2019-12-15 | EOX | 1 | N | CETUXIMAB + IRINOTECAN + MDG | 101651174 |
| 20215084 | 20155469 | 1.83 | null | Palliative (P) | 2019-09-02 | 2019-09-03 | EOX | 02 | N | TRIAL | 100017471 |
| 20215090 | 20155470 | 1.72 | 58.1 | Palliative (P) | null | 2019-01-23 | EOX | N | N | EOX | 101806635 |
| 20215094 | 20155471 | 1.53 | 43.4 | null | 2018-09-06 | 2018-10-06 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100223970 |
| 20215097 | 20155472 | 1.68 | 86 | Palliative (P) | 2017-01-22 | 2017-01-26 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101284377 |
| 20215101 | 20155473 | 1.74 | 88.2 | Palliative (P) | 2018-03-06 | 2018-03-06 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 99 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101338233 |
| 20215106 | 20155474 | 1.83 | null | Curative (C) | 2021-06-14 | 2021-07-10 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101314334 |
| 20215107 | 20155475 | 1.9 | 77.5 | Neo-adjuvant (N) | 2017-12-15 | 2018-12-27 | EOX | N | N | EOX | 100046321 |
| 20215108 | 20155476 | 1.73 | 86.9 | null | 2017-08-29 | 2017-08-29 | Sorafenib | 02 | null | SORAFENIB | 101198685 |
| 20215109 | 20155477 | 1.75 | 93.4 | null | 2021-12-14 | 2021-12-19 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101705105 |
| 20215125 | 20155478 | 1.69 | 96 | Neo-adjuvant (N) | null | 2018-04-14 | EOX | N | Y | CAPECITABINE + RT | 100798125 |
| 20215126 | 20155479 | 1.74 | 90.7 | Palliative (P) | 2018-03-08 | 2018-08-09 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101584161 |
| 20215134 | 20155480 | 1.83 | 91 | Palliative (P) | 2018-05-23 | 2018-07-22 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 100202876 |
| 20215137 | 20155481 | 1.61 | 76 | Palliative (P) | null | 2020-04-03 | IRINOTECAN + MDG + PANITUMUMAB | 01 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100128164 |
| 20215142 | 20155482 | 1.66 | 54.7 | null | 2017-03-13 | 2017-03-24 | EOX | 2 | null | EOX | 101810485 |
| 20215146 | 20155483 | 1.87 | 61 | Neo-adjuvant (N) | 2017-12-20 | 2017-12-20 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 2 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100094289 |
| 20215154 | 20155484 | 1.83 | 73.4 | Curative (C) | 2017-12-28 | 2018-01-10 | EOX | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100575560 |
| 20215156 | 20155485 | 1.72 | null | Palliative (P) | 2020-10-21 | 2020-11-08 | EOX | Y | N | CETUXIMAB + IRINOTECAN + MDG | 101497143 |
| 20215159 | 20155486 | 1.88 | 71.2 | Palliative (P) | 2019-10-28 | 2019-12-08 | Capecitabine 35days + RT | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101172881 |
| 20215160 | 20155487 | 1.87 | 80 | Palliative (P) | 2020-12-23 | 2021-01-08 | Sorafenib | 02 | N | SORAFENIB | 101436141 |
| 20215165 | 20155488 | 1.79 | 67 | Curative (C) | 2020-05-08 | 2020-08-17 | EOX | N | Y | EOX | 100187047 |
| 20215169 | 20155489 | 1.63 | 96.2 | Palliative (P) | 2017-11-14 | 2017-12-06 | Capecitabine 35days + RT | 02 | N | CAPECITABINE + RT | 100785299 |
| 20215175 | 20155490 | 1.72 | 58.2 | Palliative (P) | null | 2020-06-07 | Sorafenib | N | N | SORAFENIB | 101254915 |
| 20215176 | 20155491 | 1.63 | 82.3 | Palliative (P) | null | 2020-09-26 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101713117 |
| 20215179 | 20155492 | 1.7 | 51.35 | Adjuvant (A) | 2017-07-23 | 2017-07-23 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 1 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101663089 |
| 20215182 | 20155493 | 1.6 | 66.05 | Palliative (P) | 2019-12-13 | 2020-01-26 | IRINOTECAN + MDG + PANITUMUMAB | Y | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101244595 |
| 20215189 | 20155494 | 1.7 | 124 | Palliative (P) | 2019-12-01 | 2019-12-08 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101558632 |
| 20215191 | 20155495 | 0 | 67.4 | Palliative (P) | 2017-02-18 | 2017-02-25 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100148502 |
| 20215192 | 20155496 | 1.87 | 95.1 | Palliative (P) | 2019-10-23 | 2019-10-30 | EOX | 99 | N | CETUXIMAB + IRINOTECAN + MDG | 101661841 |
| 20215194 | 20155497 | 1.42 | 50.6 | Palliative (P) | 2019-11-26 | 2019-12-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101774733 |
| 20215203 | 20155498 | 1.62 | 57 | Neo-adjuvant (N) | 2020-05-08 | 2020-05-08 | CAPECITABINE + RT | N | Y | CAPECITABINE + RT | 101820639 |
| 20215205 | 20155499 | 1.79 | 75 | Palliative (P) | 2016-05-02 | 2016-05-23 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101605789 |
| 20215206 | 20155500 | 1.79 | 58.1 | Palliative (P) | 2021-08-20 | 2021-09-03 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100066797 |
| 20215209 | 20155501 | 1.75 | 75.9 | Neo-adjuvant (N) | 2019-02-13 | 2019-06-16 | Sorafenib | Y | Y | SORAFENIB | 100151323 |
| 20215210 | 20155502 | 1.68 | 68.5 | Palliative (P) | 2019-04-01 | 2019-04-21 | EOX | 99 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101350211 |